Beatriz Veiga | Neuroscience | Best Researcher Award

Published on by Academic Awards

Dr. Beatriz Veiga | Neuroscience | Best Researcher Award

Dr. Beatriz Veiga, Universidade Federal de São Paulo, Brazil

Dr. Beatriz Azevedo dos Anjos Godke Veiga is a Brazilian neurologist with a focus on movement disorders. She completed her medical degree in 2001 at Universidade Estadual de Londrina, followed by a Master’s and Doctorate in Neurology/Neurosciences at Universidade Federal de São Paulo (UNIFESP). Her doctoral research, completed in 2023, examined the association between compulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients. Dr. Veiga is currently a neurologist at Hospital Ipiranga and a faculty member at Universidade Nove de Julho. Her research interests include impulsive behaviors, dyskinesias, and Parkinson’s disease. She has received multiple awards, including the International Congress Travel Grant Award from the Movement Disorders Society in 2019 and 2022. Her published work includes articles on depression in Parkinson’s disease and fatigue in geriatric patients. Dr. Veiga is actively involved in several research projects, particularly those exploring the relationship between early-onset Parkinson’s disease and dopamine agonists.

Publication Profile

Orcid

Awards and Titles 🏆

Dr. Beatriz Veiga has earned significant recognition in the field of movement disorders. In 2022, she was awarded the International Congress Travel Grant Award by the Movement Disorders Society 🌍, highlighting her contributions and research in this specialized area. This prestigious honor was preceded by another International Congress Travel Grant Award in 2019, further solidifying her standing within the international scientific community. Dr. Veiga’s continuous dedication to advancing the understanding of movement disorders has positioned her as a prominent figure in the field, earning accolades for her expertise and commitment to research. 🌟

 

Academic Background 🎓

Dr. Beatriz Veiga’s academic journey has been marked by excellence in the field of Neurology and Neurosciences. She completed her PhD in Neurology/Neurosciences at the Federal University of São Paulo (UNIFESP), Brazil, in 2023, with a thesis on the association between compulsive impulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients 🧠. Dr. Veiga also holds a Master’s degree from UNIFESP (2008), focusing on depression in Parkinson’s disease. Her medical residency in Neurology was completed at the State University of Londrina (UEL), Brazil, where she was a CNPq scholar. She holds a degree in Medicine from UEL (2001). 🎓

 

Complementary Education 📚

Dr. Beatriz Veiga has enhanced her expertise in Neurology through specialized training. In 2019, she completed a short course in Deep Brain Stimulation (DBS) at the International Academy, gaining 25 hours of focused learning on this advanced therapy for movement disorders 🧠. She also participated in an Observership program at the Movement Disorders Clinic, University of Toronto, with a focus on DBS, accumulating 160 hours of hands-on experience. Dr. Veiga is a Neurologist and Preceptor at Hospital Ipiranga, and a faculty member at the University of Nove de Julho, specializing in movement disorders. 💡

 

Professional Experience 🏥

Dr. Beatriz Veiga has extensive professional experience in Neurology and academia. Since 2008, she has been a Full Member of the Academia Brasileira de Neurologia (ABN). She is also an active member of the Movement Disorder Society (MDS) since 2017. Dr. Veiga is a Faculty Member at the University of Nove de Julho (UNINOVE) since 2012, where she teaches in the Medicine program 🩺. Additionally, she has served as a Neurologist and Preceptor at Hospital Ipiranga since 2010, training the next generation of neurologists. Her expertise has been pivotal in the field of movement disorders. 🌟

 

Research Focus

Dr. Beatriz A. Anjos G. Veiga’s research primarily focuses on neurology and movement disorders, specifically the relationship between impulsive-compulsive behaviors (ICBs) and Levodopa-induced dyskinesia (LID) in Parkinson’s disease. Her work, demonstrated in the study “Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia?”, explores how these behaviors contribute to the clinical presentation of Parkinson’s disease and its treatment. She investigates the neurophysiological mechanisms behind these effects, aiming to improve therapeutic strategies. Her research contributes significantly to understanding the cognitive and motor complications of Parkinson’s disease and optimizing management strategies. 🩺🔬

 

Publication Top Notes

Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia? A Brazilian Cross-Sectional Study

Yinyan Wang | Neuroimaging Award | Best Researcher Award

Published on by Academic Awards

Dr. Yinyan Wang | Neuroimaging Award | Best Researcher Award

Dr. Yinyan Wang, Bejing Tiantan Hospital, China

Dr. Yinyan Wang, an accomplished neurosurgeon and researcher, serves as an Attending Surgeon at Beijing Tiantan Hospital. With expertise in brain functional mapping and radiomics, he has authored 70 SCI publications and holds several national patents. Dr. Wang leads prominent projects including the Beijing Natural Science Foundation and National Natural Science Foundation initiatives. His contributions to neurosurgery include pioneering methods in functional MRI and glioma research, recognized with multiple prestigious awards. As PI of China National Clinical Research Center for Neurological Diseases and China Institute for Brain Research, he continues to advance neuroscience, integrating international training from Finland, Germany, and the Netherlands. 🧠✨

 

Publication profile

🎓 Education Background

He obtained his Ph.D. and Master’s degrees in Neurosurgery from Capital Medical University, following a Bachelor’s in Clinical Medicine.

👨‍⚕️ Working Experience

Starting as a resident doctor and now serving as Deputy Chief Surgeon, his career highlights include roles as Associate Professor and Attending Surgeon.

🏆 Awards

Recognized for his contributions, he holds key positions in national research centers and medical committees, driving advancements in neurology.

 

 

Research Focus

Dr. Wang Y. focuses on advancing the understanding and treatment of neurological conditions, particularly gliomas. His research spans diverse areas including pre-operative brain mapping and radiomics-based machine learning for brain tumors. 🧠 His contributions are widely recognized with numerous publications in esteemed journals, showcasing innovative approaches in clinical neuroimaging and neurosurgery. Dr. Wang’s work not only enhances surgical techniques but also pioneers new methods in functional MRI and data analysis. His commitment to improving outcomes for patients with brain tumors underscores his significant impact in the field of neuroscience. 🌟

Publication Top Notes

  • Model construction and multi-objective performance optimization of a biodiesel-diesel dual-fuel engine based on CNN-GRU 🚗 Wang, H. et al., Energy, 2024,
  • Structural changes in eloquent cortex secondary to glioma in sensorimotor area 🧠 Guo, Y. et al., Human Brain Mapping, 2024,
  • Construction of digital twin model of engine in-cylinder combustion based on data-driven 🛠️ Hu, D. et al., Energy, 2024,
  • The effect of changing EGR rate on engine performance under different ammonia/methanol ratios 🚚 Yang, C. et al., Journal of the Energy Institute, 2024, Effects of combustion and emission performance of ammonia/natural gas engines ignited by diesel ⛽ Wang, B. et al., Fuel, 2024, cited by: 6
  • Construction and verification of dual-fuel engine combustion model 🔥 Hu, D. et al., Journal of the Energy Institute, 2024,
  • Effect of different ammonia/methanol ratios on engine combustion and emission performance 🌡️ Wang, B. et al., Applied Thermal Engineering, 2024, cited by: 14
  • Research on surrogate models and optimization algorithms of compressor characteristic based on digital twins 🔄 Yang, Q. et al., Journal of Engineering Research (Kuwait), 2024, cited by: 0
  • Effect of different ammonia mixing methods for diesel ignition on combustion and emission performance of high pressure common rail engine 🚛 Wang, B. et al., Journal of the Energy Institute, 2023, cited by: 5
  • Development of an integrated predictive model for postoperative glioma-related epilepsy using gene-signature and clinical data 🧬 Li, L. et al., BMC Cancer, 2023, cited by: 1

MELINA MORAES | Neuroscience | Best Researcher Award

Published on by Academic Awards

Mrs. MELINA MORAES | Neuroscience | Best Researcher Award

Mrs. MELINA MORAES, Paulist School of Medicine, Brazil

Mrs. Melina Moraes is a distinguished professional affiliated with the Paulist School of Medicine in Brazil. With a robust background in medical sciences, she has contributed significantly to the academic and clinical community. Her expertise spans various aspects of medicine, and she is recognized for her dedication to advancing medical education and research. As a respected member of the Paulist School of Medicine, Mrs. Moraes plays a crucial role in shaping the future of healthcare in Brazil.

Publication Profile

Google Scholar

Summary:

I am an experienced Lecturer at the School of Mechanical and Chemical Engineering, Wollo University, with a robust background in chemical engineering and a focus on biodiesel production and alternative fuels. I have a strong academic and industrial background, with practical experience as a Production Chemist and an academic role that includes teaching, research, and student advisement. I hold an MSc in Chemical Engineering with a specialization in Process Engineering from Bahir Dar University.

Education

MSc in Chemical Engineering (Process Engineering),Bahir Dar University, Institute of Technology, Bahir Dar, Ethiopia,October 27, 2018 – November 11, 2020,Thesis: “Synthesis and Characterization of Biodiesel From Desert Date (Balanites Aegyptiaca) Seed Kernel Oil Via NaOH catalyzed trans-esterification reaction system.”,BSc in Chemical Engineering,Wollo University, Kombolcha Institute of Technology, Wollo, Ethiopia,November 22, 2011 – June 30, 2016,Project: “Production of bio-ethanol from corn cob.”,Higher Diploma in Higher Education Teaching,Wollo University, Kombolcha Institute of Technology,October 2, 2017 – July 3, 2018

 

Research Focus:

  • Biodiesel production and characterization
  • Alternative fuels and renewable energy sources
  • Catalysis and chemical reaction optimization
  • Waste valorization and environmental sustainability

Experience:

Lecturer,School of Mechanical and Chemical Engineering, Wollo University, Kombolcha Institute of Technology, Wollo, Ethiopia,November 12, 2020 – Present,Responsibilities: Conducting and reviewing research, lecturing, managing laboratory sessions, advising students, and preparing educational materials.,Assistant Lecturer,School of Mechanical and Chemical Engineering, Wollo University, Kombolcha Institute of Technology, Wollo, Ethiopia,September 13, 2017 – October 26, 2018,Responsibilities: Conducting tutorials, managing laboratory sessions, advising students, and preparing educational materials.,Production Chemist,Kombolcha Tannery PLC, Wollo, Ethiopia,December 6, 2016 – September 12, 2017,Responsibilities: Controlling the leather production process, ensuring quality through correct chemical formulations, managing waste discharge systems, and coordinating beam-house operations.

Awards and Certifications:

Invited Reviewer for journals indexed in the Web of Science.,Assessment program on Alternate Fuels Research (December 30, 2020).,Quality Control and Industrial Safety Training (Summer 2018).,International Virtual Conference on Advances in Colloidal & Polymeric Systems (August 22, 2020).,International Webinar on Entrepreneurship (February 11, 2021).,Financial Analysis Fundamentals Certification (July 5, 2022).

Publication Top Notes

  • Phytochemical property and antimicrobial activity of Ficifolius A. Rich root extract. Heliyon 2024, VOLUME 10, ISSUE 11, E31921. IF 2022: 4 Heliyon.
  • Alternative Methods for Biodiesel Cetane Number Valuation: A Technical Note. ACS Omega 2024, 9, 6, 6296–6304. IF 2022: 4.1 ACS Omega.
  • OH-Impregnated Household Bleach-Making Sediments for the Catalysis of Waste Cooking Oil Transesterification: Parameter Optimization. ACS Omega 2024, 9, 4, 4613–4626. IF 2022: 4.1 ACS Omega.
  • Valorization of calcium hypochlorite precipitate as a new source of heterogeneous catalyst development for biodiesel production: A preliminary experiment. Heliyon 2023, 9, 11, E21959. IF 2022: 4 Heliyon.
  • Fourier transform infrared spectroscopy as a tool for identifying the unique characteristic bands of lipid in oilseed components: Confirmed via Ethiopian indigenous desert date fruit. Heliyon 2023, 9, 4, e14699. IF 2022: 4 Heliyon.
  • Formulation of Neem Leaf and Croton Seed Essential Oils as a Natural Insecticide Tested on Mosquitoes and Cockroaches. ACS Omega 2023, 8, 17, 15052–15061. IF 2022: 4.1 ACS Omega.
  • NaOH-Catalised Methanolysis Optimization of Biodiesel production from Desert Date Seed Kernel Oil. ACS Omega 2021, 6, 37, 24082–24091. IF 2022: 4.1 ACS Omega.

Linjing Mu | Brain PET Imaging Award | Best Researcher Award

Published on by Academic Awards

Dr. Linjing Mu | Brain PET Imaging Award | Best Researcher Award

Dr. Linjing Mu, ETH Zurich, Switzerland

🔬 Dr. Linjing Mu pursued doctoral research at Nankai University, followed by a post-doctoral fellowship at Basel University, Switzerland. With expertise in radiopharmaceutical sciences, Dr. Mu led research teams at University Hospital Zurich and ETH Zurich, focusing on lead structure discovery, ligand synthesis, and radiolabeling method development. A prolific author, Dr. Mu has 106 peer-reviewed publications, including 10 as last and corresponding author, and 19 as the first author. Co-investigator on 10 patents, Dr. Mu has presented internationally and collaborated with industry leaders like Bayer Schering, Novartis, and Roche, contributing significantly to drug discovery and clinical translations.

 

Publication Profile:

Scopus

Orcid

Education:

Doctoral Research in Chemistry Department, Nankai University (1993-1996)

Post-Doctoral Fellow, Basel University, Switzerland (1996-2001)

Experience:

Team Leader in the field of Radiopharmaceutical Sciences, Group of Prof. Schubiger (2001-2010)

Head of Research, Radiopharmacy, University Hospital Zurich (2010-2021)

Senior Scientist, Prof. Schibli’s Group, ETH Zurich (2021-Present)

Research Expertise:

Lead Structure Finding based on Literature and Patents

Design and Synthesis of Novel Ligands

Structure-Activity Relationship Studies

Radiolabeling Method Development

In Vitro and In Vivo Evaluation

Academic Achievements:

Co-authored 106 Peer-Reviewed Publications

Last and Corresponding Author on 10, First Author on 19 (H-Factor 29, Scopus)

Co-Investigator on 10 Patent Applications

Contributed to International Conferences as Invited Speaker, Oral and Poster Presenter

Research Focus:

🔬 Dr. Linjing Mu’s research focus lies at the intersection of neuroimaging and drug development, particularly in the field of molecular imaging for neurodegenerative diseases like Alzheimer’s. Their work encompasses the development and optimization of radioligands targeting specific molecular pathways implicated in neurodegeneration. Through PET/MRI studies and the exploration of novel PET tracers, such as (R)-[18F]YH134 and (R)-[18F]PSS232, Dr. Mu aims to deepen our understanding of disease mechanisms and identify potential therapeutic targets. This research not only sheds light on disease pathology but also paves the way for the development of new diagnostic tools and pharmacological interventions.

 

Publication Top Notes:

📄 Wang, J. et al. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI study. Published in Alzheimer’s Research and Therapy, 2024. Cited by: 0.

📄 He, Y. et al. Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development. Published in Journal of Nuclear Medicine, 2024. Cited by: 0.

📄 Boccalini, C. et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Published in Alzheimer’s and Dementia, 2024. Cited by: 1.

📄 Trachsel, B. et al. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK. Published in EJNMMI Radiopharmacy and Chemistry, 2023. Cited by: 0.

📄 Lu, Y. et al. Proof-of-concept optimization of a copper-mediated 18F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation. Published in Lab on a Chip, 2023. Cited by: 1.

📄 Ni, R. et al. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion. Published in Photoacoustics, 2023. Cited by: 0.

📄 Zechner, M. et al. In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143. Published in Journal of Medicinal Chemistry, 2023. Cited by: 1.

📄 Bengs, S. et al. Rest/stress myocardial perfusion imaging by positron emission tomography with 18F-Flurpiridaz: A feasibility study in mice. Published in Journal of Nuclear Cardiology, 2023. Cited by: 3.

📄 Peretti, D.E. et al. ATN profile classification across two independent prospective cohorts. Published in Frontiers in Medicine, 2023. Cited by: 0.

📄 He, Y. et al. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain. Published in European Journal of Medicinal Chemistry, 2022. Cited by: 2.